Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Wedemeyer

Showing results (71-80 of 151) with videos related to

Pageof 16
Sort By:
Journal of Viral Hepatitis|December 17, 2009
Hepatitis E in HIV-positive patients in a low-endemic countryS Pischke, H Ho, F Urbanek, et al.
Journal of Viral Hepatitis|June 23, 2011
Adefovir serum levels do not differ between responders and nonrespondersK Deterding, L Naesens, M Buti, et al.
HIV Medicine|October 15, 2013
Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up studyD Ernst, M Greer, R Akmatova, et al.
Hepato-Gastroenterology|October 2, 1998
Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis CH Wedemeyer, J Ockenga, H Frank, et al.
Journal of Viral Hepatitis|February 1, 2008
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infectionS Ciesek, H Liermann, J Hadem, et al.
Zeitschrift Fur Gastroenterologie|August 17, 2012
[Costs of guideline-based treatment of hepatitis B patients in Germany]J T Stahmeyer, H Becker, S Heidelberger, et al.
Journal of Viral Hepatitis|July 6, 2012
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeksM P Manns, H Wedemeyer, A Singer, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosisF Mettke, B Schlevogt, K Deterding, et al.
The New England Journal of Medicine|January 17, 2002
Treatment of acute hepatitis C with interferon alfa-2bE Jaeckel, M Cornberg, H Wedemeyer, et al.
Gut|February 15, 2001
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis CB Wesche, E Jaeckel, C Trautwein, et al.
Pageof 16

Showing results (71-80 of 151) with videos related to

Sort By:
Pageof 16
Journal of Viral Hepatitis|December 17, 2009
Hepatitis E in HIV-positive patients in a low-endemic countryS Pischke, H Ho, F Urbanek, et al.
Journal of Viral Hepatitis|June 23, 2011
Adefovir serum levels do not differ between responders and nonrespondersK Deterding, L Naesens, M Buti, et al.
HIV Medicine|October 15, 2013
Impact of GB virus C viraemia on clinical outcome in HIV-1-infected patients: a 20-year follow-up studyD Ernst, M Greer, R Akmatova, et al.
Hepato-Gastroenterology|October 2, 1998
Perihepatic lymphadenopathy: a marker of response to interferon alpha in chronic hepatitis CH Wedemeyer, J Ockenga, H Frank, et al.
Journal of Viral Hepatitis|February 1, 2008
Impaired TRAIL-dependent cytotoxicity of CD1c-positive dendritic cells in chronic hepatitis C virus infectionS Ciesek, H Liermann, J Hadem, et al.
Zeitschrift Fur Gastroenterologie|August 17, 2012
[Costs of guideline-based treatment of hepatitis B patients in Germany]J T Stahmeyer, H Becker, S Heidelberger, et al.
Journal of Viral Hepatitis|July 6, 2012
Glycyrrhizin in patients who failed previous interferon alpha-based therapies: biochemical and histological effects after 52 weeksM P Manns, H Wedemeyer, A Singer, et al.
Alimentary Pharmacology & Therapeutics|December 6, 2017
Interferon-free therapy of chronic hepatitis C with direct-acting antivirals does not change the short-term risk for de novo hepatocellular carcinoma in patients with liver cirrhosisF Mettke, B Schlevogt, K Deterding, et al.
The New England Journal of Medicine|January 17, 2002
Treatment of acute hepatitis C with interferon alfa-2bE Jaeckel, M Cornberg, H Wedemeyer, et al.
Gut|February 15, 2001
Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis CB Wesche, E Jaeckel, C Trautwein, et al.
Pageof 16